In IIM, cohort studies have demonstrated higher levels of circulating VCAM-1, ET-1, thrombomodulin, and plasminogen activator inhibitor-1 in IIM patients with ILD compared to IIM without lung disease [26, 27]. The gene discussed is THBD; the disease is interstitial lung disease.